CD44 and breast cancer: Cells isolated from human breast cancers marked by CD44+CD24−/low lineage are anoikis-resistant and capable of self-renewal as mammosphere (MS) colonies providing a link between MS and cell surface markers that enrich for tumorgenic cells [14], [15].